Interaction of Galectin-3 Concentrations with the Treatment Effects of beta-Blockers and RAS Blockade in Patients with Systolic Heart Failure: A Derivation-Validation Study from TIME-CHF and GISSI-HF

Sandra Sanders-van Wijk*, Serge Masson, Valentina Milani, Peter Rickenbacher, Marco Gorini, Luigi T. Tavazzi, Daniel Tobler, Hans Rickli, Roberto Latini, Hanspeter Brunner-La Rocca

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)605-616
JournalClinical Chemistry
Issue number4
Publication statusPublished - Apr 2016

Cite this